95 related articles for article (PubMed ID: 6230536)
21. Potent versus mild acid suppression in peptic ulcer disease.
Howden CW
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():45-6. PubMed ID: 1349552
[TBL] [Abstract][Full Text] [Related]
22. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
23. Peptic ulcer disease.
Hawker P
Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
[TBL] [Abstract][Full Text] [Related]
24. Ulcer-healing drugs and endogenous prostaglandins.
Guslandi M
Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):398-402. PubMed ID: 2864318
[TBL] [Abstract][Full Text] [Related]
25. [The effects of gastric acid inhibitors].
van de Ven LL
Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1285. PubMed ID: 2755529
[No Abstract] [Full Text] [Related]
26. Drug treatment of peptic ulcer syndrome.
Fielding JF
Ir Med J; 1982 Oct; 75(10):379-82. PubMed ID: 7174254
[No Abstract] [Full Text] [Related]
27. Acid suppression and ulcer healing: dichotomy, degree, and dilemma.
Hunt RH
Am J Gastroenterol; 1988 Sep; 83(9):964-6. PubMed ID: 2901221
[No Abstract] [Full Text] [Related]
28. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
29. Proton pump inhibitors and acid-related diseases.
Sachs G
Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
[TBL] [Abstract][Full Text] [Related]
30. The use of neem for controlling gastric hyperacidity and ulcer.
Maity P; Biswas K; Chattopadhyay I; Banerjee RK; Bandyopadhyay U
Phytother Res; 2009 Jun; 23(6):747-55. PubMed ID: 19140119
[TBL] [Abstract][Full Text] [Related]
31. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
32. Pirenzepine: a selective anticholinergic for peptic ulcer.
Drug Ther Bull; 1985 Apr; 23(8):29-31. PubMed ID: 3888582
[No Abstract] [Full Text] [Related]
33. [Use of gastrocepin in middle-aged and elderly patients with peptic ulcer].
Kapitanenko AM; Shastin IV; Karnaukhov IuN; Merkur'ev ND; Smirnov PA
Klin Med (Mosk); 1986 Mar; 64(3):95-6. PubMed ID: 3520141
[No Abstract] [Full Text] [Related]
34. [Recent state of therapy of peptic disease].
Pavlotzky M; Eshchar J
Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295
[No Abstract] [Full Text] [Related]
35. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
36. [Selective muscarinic receptor antagonists].
Kishimoto S; Kajiyama G; Miyoshi A
Nihon Rinsho; 1984 Jan; 42(1):114-9. PubMed ID: 6371305
[No Abstract] [Full Text] [Related]
37. [Treatment of gastroduodenal ulcer with ulcosilvanil].
Puşcaş I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):49-61. PubMed ID: 2884711
[No Abstract] [Full Text] [Related]
38. [The therapeutic arsenal in the medical treatment of gastroduodenal ulcer disease].
Vallot T; Bonfils S
Rev Prat; 1985 Feb; 35(9):449-57. PubMed ID: 3983550
[No Abstract] [Full Text] [Related]
39. [Will anti-ulcer drugs soon differ only in their side effects?].
Miederer SE
Fortschr Med; 1986 Dec; 104(3):918-20. PubMed ID: 2881864
[No Abstract] [Full Text] [Related]
40. A pharmacological approach to gastric acid inhibition.
Esplugues JV
Drugs; 2005; 65 Suppl 1():7-12. PubMed ID: 16335853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
